Neuronetics (STIM)
(Delayed Data from NSDQ)
$1.80 USD
+0.02 (1.12%)
Updated Aug 2, 2024 04:00 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Neuronetics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -30.19 | -37.16 | -31.19 | -27.45 | -29.04 |
Depreciation/Amortization & Depletion | 2.01 | 1.65 | 1.06 | 0.94 | 1.07 |
Net Change from Assets/Liabilities | -14.10 | -4.78 | -6.64 | -8.28 | -6.91 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.25 | 9.55 | 8.79 | 6.40 | 4.41 |
Net Cash From Operating Activities | -32.04 | -30.74 | -27.98 | -28.39 | -30.48 |
Property & Equipment | -2.37 | -3.27 | -2.35 | -0.73 | -0.81 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 1.05 | 10.00 | -7.49 | 0.00 | 0.00 |
Net Cash from Investing Activities | -1.32 | 6.73 | -9.84 | -0.73 | -0.81 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.30 | 83.41 | 0.69 | 2.42 |
Issuance (Repayment) of Debt | 23.80 | 0.00 | 0.00 | 2.50 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.10 | -0.09 | -0.40 | -0.82 | 0.00 |
Net Cash from Financing Activities | 22.70 | 0.21 | 83.01 | 2.37 | 2.42 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -10.66 | -23.80 | 45.18 | -26.75 | -28.88 |
Cash at Beginning of Period | 70.34 | 94.14 | 48.96 | 75.71 | 104.58 |
Cash at End of Period | 59.68 | 70.34 | 94.14 | 48.96 | 75.71 |
Diluted Net EPS | -1.05 | -1.38 | -1.22 | -1.46 | -1.58 |
Fiscal Year End for Neuronetics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -7.87 | -30.19 | -24.81 | -15.42 |
Depreciation/Amortization & Depletion | NA | 0.56 | 2.01 | 1.50 | 1.00 |
Net Change from Assets/Liabilities | NA | -6.84 | -14.10 | -19.29 | -13.52 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.14 | 10.25 | 8.43 | 3.89 |
Net Cash From Operating Activities | NA | -12.02 | -32.04 | -34.17 | -24.05 |
Property & Equipment | NA | -0.38 | -2.37 | -1.49 | -0.94 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.44 | 1.05 | 0.73 | 0.11 |
Net Cash from Investing Activities | NA | 0.07 | -1.32 | -0.76 | -0.83 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 23.80 | 1.30 | 1.30 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | -1.10 | -0.86 | -0.86 |
Net Cash from Financing Activities | NA | 0.00 | 22.70 | 0.44 | 0.44 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -11.95 | -10.66 | -34.49 | -24.44 |
Cash at Beginning of Period | NA | 59.68 | 70.34 | 70.34 | 70.34 |
Cash at End of Period | NA | 47.73 | 59.68 | 35.85 | 45.91 |
Diluted Net EPS | NA | -0.27 | -0.17 | -0.33 | -0.17 |